MEDVi vs Calibrate for Weight Loss: 2026 Comparison
An independent, side-by-side comparison of MEDVi and Calibrate for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Calibrate
Starting at $299/mo vs $Infinity/mo
Most Medications
Calibrate
3 medications vs 2
Best for Beginners
MEDVi
Hybrid, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | MEDVi | Calibrate | Savings |
|---|---|---|---|
| Semaglutide | Not offered | $299/monthly | Only at Calibrate |
| Tirzepatide | Not offered | $299/monthly | Only at Calibrate |
| Liraglutide | Not offered | $299/monthly | Only at Calibrate |
Pros and Cons
MEDVi
- Video consultations with board-certified physicians
- Brand-name GLP-1 medications and orforglipron ($149/mo oral option) available
- Metabolic health coaching included at no extra cost
- Follow-up visits every 4-6 weeks
- Broad state coverage (47 states)
- Insurance accepted for brand-name medications
- Compounded GLP-1 options permanently unavailable
- Lab work not included in the program
- Founded in 2022 with a limited public track record compared to established competitors
- Physicians are not specifically obesity medicine specialists
- The "concierge" branding may set expectations higher than the actual level of personalization
- Not available in all 50 states
Calibrate
- Comprehensive metabolic health program (not just medication)
- Lab testing and metabolic panels included
- Video consultations with obesity medicine specialists
- Works with insurance to cover GLP-1 medication costs
- Focus on sustainable weight loss and metabolic reset
- Higher program cost ($299/mo for coaching + medication separate)
- One-year commitment required
- Insurance coverage for medication not guaranteed
- Not available in all states
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By maria-torres · Last updated April 1, 2026
MEDVi vs Calibrate for Weight Loss: 2026 Comparison
Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.
MEDVi and Calibrate occupy the same tier of the telehealth weight loss market: both charge a program fee on top of medication costs, both include physician consultations and coaching, and both work with brand-name medications through insurance. The differences are in clinical depth, pricing transparency, and what each is willing to guarantee.
Calibrate is the more established program — board-certified obesity physicians, included lab work, and a 10%+ weight loss money-back guarantee. MEDVi is newer, emphasizes more frequent physician touchpoints, and positions orforglipron (pending FDA approval; PDUFA date April 10, 2026) as a $149/month medication entry point. Neither is appropriate for patients who want a low-cost prescription-only service — both are clinical programs at clinical program prices.
Pricing last verified April 2026. We update pricing data monthly. Note: MEDVi's current program fee is not publicly listed on their website — verify at medviclinic.com before enrolling.
How do MEDVi and Calibrate compare on price?
Calibrate charges $199/month for the program fee. Total cost depends on which medication is prescribed and whether insurance covers it.
MEDVi's program fee is not publicly posted. Total cost at MEDVi also depends on medication and insurance coverage. Verify MEDVi's current program fee directly at medviclinic.com before comparing — this table uses estimated figures from April 2026 and should be confirmed.
| MEDVi | Calibrate | |
|---|---|---|
| Program fee | Verify at medviclinic.com | $199/mo |
| Orforglipron (pending FDA approval) | ~$149/mo + program fee | ~$149/mo + $199/mo = ~$348/mo total |
| Brand Wegovy (with insurance) | Insurance copay + program fee | ~$25/mo copay + $199/mo |
| Brand Zepbound (with insurance) | Insurance copay + program fee | Insurance copay + $199/mo |
| Lab work | Additional cost (partner labs) | Included in program |
| Weight loss guarantee | No | Yes (10%+ or money back — read terms) |
| HSA/FSA eligible | Yes | Yes |
| State availability | 47 states | Most states |
Calibrate's included lab panels offset part of the program fee — baseline metabolic panels, lipid profiles, and A1C are standard. MEDVi charges separately for labs through partner facilities. For patients who need initial metabolic workup, Calibrate's all-in lab cost is a real pricing advantage.
Calibrate requires a 3-month initial commitment ($597 upfront) — a material cost for budget-conscious patients before the month-to-month rate kicks in. The monthly fee drops to $199/month after that, but the upfront cost matters.
What are the clinical differences between MEDVi and Calibrate?
Calibrate's clinical credentialing is the strongest in this comparison. Calibrate uses board-certified obesity medicine physicians — a specialization that requires dedicated training in metabolic health and GLP-1 prescribing beyond a standard internal medicine or family practice background. Calibrate also publishes three-year outcome data from their patient cohort, which is unusual in direct-to-consumer telehealth.
MEDVi positions itself around physician access frequency — more touchpoints per month than most telehealth programs. Video consultations are available (not async-only). MEDVi's clinical team includes metabolic health specialists. As a newer platform (founded 2022), MEDVi has less published outcome data than Calibrate.
| Clinical factor | MEDVi | Calibrate |
|---|---|---|
| Physician certification | Metabolic health specialists | Board-certified obesity medicine |
| Published outcome data | Limited (newer platform) | 3-year cohort data available |
| Consultation model | Video consultations | Video consultations |
| Lab work | Additional cost | Included (baseline metabolic panel) |
| Dietitian access | Not confirmed | Not standard |
| Coaching | Yes (metabolic coaching) | Yes (behavioral coaching) |
How does insurance navigation compare?
Both programs work with insurance for brand-name medications. Calibrate has a more developed insurance infrastructure — their team handles prior authorization for Wegovy and Zepbound, and most commercially insured patients pay approximately $25/month copay for brand injectable GLP-1s.
MEDVi accepts insurance for brand medications but positions this as one option among several rather than a core feature. If insurance navigation for brand injectables is a priority, Calibrate's more established system is the relevant advantage.
Neither program covers compounded medications through insurance (compounded drugs are cash-pay only), and Calibrate has moved away from compounded medications as FDA enforcement has tightened.
Does Calibrate offer a weight loss guarantee that MEDVi doesn't?
Calibrate offers a money-back guarantee for patients who do not achieve at least 10% body weight loss while following the full program. MEDVi does not offer an equivalent guarantee.
The guarantee is meaningful for patients who are weighing program cost against outcome uncertainty — it reduces the financial risk of commitment. Read Calibrate's guarantee terms carefully: it requires active participation in the full program, including coaching sessions and behavioral curriculum, not just medication adherence.
What is orforglipron and how does it fit into these programs?
Orforglipron is an oral once-daily GLP-1 receptor agonist developed by Eli Lilly. It is non-peptide — meaning it can be taken as a pill without the injection mechanism of semaglutide or tirzepatide. The PDUFA date for FDA approval is April 10, 2026; verify approval status before publishing this article.
Both MEDVi and Calibrate have announced orforglipron as a medication option at approximately $149/month via LillyDirect. For Calibrate, that creates an all-in cost of approximately $348/month ($149 medication + $199 program fee). MEDVi's total would depend on their current program fee.
For patients who want to avoid injections, orforglipron at $149/month is a lower-cost entry point than injectable brand medications. Clinical trial data (ACHIEVE-1 trial) showed approximately 7–8% body weight loss at 40 weeks — less than the 14–15% achieved with semaglutide in the STEP trials, but meaningful for appropriate patients.
Who is Calibrate best for?
- Patients who want the most credentialed clinical program — Board-certified obesity physicians and published outcome data set Calibrate apart from newer competitors
- Commercially insured patients — Calibrate's insurance navigation infrastructure can reduce effective medication cost to $25/month for brand injectables
- Patients who want a weight loss guarantee — Calibrate is one of the few programs that offers a money-back option tied to a 10%+ outcome
- Patients who need initial lab work included — Calibrate's included metabolic panels remove a separate cost that MEDVi charges for
Who is MEDVi best for?
- Patients who want more frequent physician contact — MEDVi's model emphasizes physician touchpoints above what standard telehealth programs provide
- Patients specifically interested in orforglipron (pending FDA approval) — MEDVi has positioned orforglipron as a central medication option
- Patients in the 3 states Calibrate doesn't serve — MEDVi operates in 47 states; verify current state coverage at medviclinic.com
How We Evaluated
We compared MEDVi and Calibrate across five dimensions: all-in pricing at each medication tier, clinical team credentials, insurance navigation, program differentiators (guarantees, lab work), and state coverage. Calibrate's program fee is publicly available. MEDVi's is not — pricing in this guide should be verified at medviclinic.com before enrollment. Telehealth Ally has no commercial relationship with either provider.
Pricing and protocol data sourced from MEDVi's and Calibrate's public websites and verified communications, April 2026. We have no commercial relationship with either provider.
Frequently Asked Questions
Which is more expensive: MEDVi or Calibrate? Calibrate's program fee is $199/month — publicly posted. MEDVi's fee is not publicly disclosed; verify at medviclinic.com. For a meaningful cost comparison, you need MEDVi's actual program fee plus your expected medication cost (which depends on insurance coverage and which drug is prescribed). Calibrate's included lab work partially offsets its program fee for patients who need initial metabolic testing.
Does Calibrate or MEDVi offer a weight loss guarantee? Calibrate offers a money-back guarantee for patients who follow the full program and do not achieve 10%+ body weight loss. MEDVi does not offer an equivalent guarantee. Read Calibrate's guarantee terms before enrolling — participation requirements apply.
Can either help with insurance for Wegovy? Both programs work with insurance for brand-name medications. Calibrate has a more established prior authorization process — most commercially insured Calibrate patients pay approximately $25/month for brand injectable GLP-1s. MEDVi also accepts insurance for brand medications. Neither covers compounded medications through insurance.
Which has better clinical credentials? Calibrate's physicians are board-certified in obesity medicine, a specialized credential beyond standard internal medicine. Calibrate also publishes three-year patient outcome data. MEDVi uses metabolic health specialists, but as a newer platform (founded 2022) has less published outcome data.
Is MEDVi newer than Calibrate? Yes. MEDVi was founded in 2022. Calibrate has been operating longer and has more patient history and published outcome data. For patients who weigh track record heavily in their decision, Calibrate's longer operational history is the concrete advantage.
Related Resources
- Calibrate Weight Loss Review — Full Calibrate program analysis
- MEDVi GLP-1 Review — Full MEDVi assessment
- Found vs Calibrate — How Calibrate compares to another structured program
- Ro vs Calibrate 2026 — Calibrate vs a no-frills prescribing platform
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →